Development of Solid Lipid Nanoparticles as Dry Powder: Characterization and Formulation Considerations.

Area of Science:

• Pharmaceutical Technology
• Nanotechnology
• Materials Science

Background:

• Solid lipid nanoparticles (SLNs) are advanced lipid-based colloidal systems for active compound delivery.
• SLNs face challenges with physical and chemical instability during storage, necessitating stable dried formulations.
• Developing a dry SLN powder is essential for improved pharmaceutical applications and shelf-life.

Purpose of the Study:

• To identify optimal methods for producing dry solid lipid nanoparticle (SLN) powder formulations from suspensions.
• To evaluate the suitability of freeze-drying and spray-drying techniques for SLN powder production.
• To assess the impact of cryoprotectants on SLN stability during drying processes.

Main Methods:

• SLN suspensions were dried using both freeze-drying and spray-drying techniques.
• Nanotechnological parameters, system morphology, and thermal behavior (differential scanning calorimetry) were analyzed.
• Cryoprotective effects of glucose and mannitol were investigated during freeze-thaw cycles and freeze-drying.

Main Results:

• Both freeze-drying and spray-drying successfully produced SLN dry powders, albeit with varying yields.
• Optimized freeze-drying conditions yielded a dry SLN powder with excellent reconstitution properties and preserved technological parameters.
• Glucose, particularly at 1% w/v, demonstrated superior cryoprotective efficacy against particle growth during all freeze-drying stages.

Conclusions:

• Freeze-drying and spray-drying are viable methods for obtaining stable SLN dry powders for pharmaceutical applications.
• Optimized freeze-drying, utilizing 1% glucose as a cryoprotectant, is highly effective in maintaining SLN integrity and functionality.
• The development of stable, dried SLN formulations significantly enhances their potential for pharmaceutical drug delivery.